TP53 and acute kidney injury: Regarding EFS, AKI was associated with a higher HR in the subgroups mentioned above, as well as patients aged >75 years, male patients, patients with a higher expected benefit according to mPRS, patients without complex karyotype, wildtype NPM1, and mutated TP53 (Figure S5).